President Donald Trump (R-FL) announced nearly a dozen [1] new drug-pricing deals during a live event at the White House on Monday.
The move targets the rising costs of prescription medications and insurance, aiming to reduce the financial burden on American patients.
Speaking at 3 p.m. Eastern Time [2], the president focused on the necessity of lowering costs for essential medical treatments. The announcement comes as part of a broader push to increase the affordability of the U.S. healthcare system.
"We’re going to make healthcare affordable," Trump said [3].
The event, held in Washington, D.C., detailed the administration's efforts to negotiate lower prices for medications. The president said that the new deals are intended to provide immediate relief from rising costs for citizens across the country.
While the administration did not list every specific medication included in the agreements, the focus remains on high-cost prescriptions that impact a significant portion of the population. The White House event was streamed live to outline these changes in drug-pricing structures.
Government officials said the initiative is designed to create a more sustainable pricing model for pharmaceuticals. By securing these deals, the administration intends to lower the out-of-pocket expenses for patients, and reduce the overall cost of insurance premiums.
“"We’re going to make healthcare affordable,"”
This initiative represents a direct intervention by the executive branch into pharmaceutical pricing, shifting toward a negotiation-based model to control healthcare inflation. By securing specific drug-pricing deals, the administration is attempting to lower costs without overhauling the entire insurance framework, focusing instead on the immediate price of prescriptions.
